These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24180745)

  • 41. Modulating retinoid X receptor with a series of (E)-3-[4-hydroxy-3-(3-alkoxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)phenyl]acrylic acids and their 4-alkoxy isomers.
    Pérez Santín E; Germain P; Quillard F; Khanwalkar H; Rodríguez-Barrios F; Gronemeyer H; de Lera AR; Bourguet W
    J Med Chem; 2009 May; 52(10):3150-8. PubMed ID: 19408900
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enantioselective syntheses of potent retinoid X receptor ligands: differential biological activities of individual antipodes.
    Vuligonda V; Thacher SM; Chandraratna RA
    J Med Chem; 2001 Jul; 44(14):2298-303. PubMed ID: 11428923
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endogenous retinoic acid receptor (RAR)-retinoid X receptor (RXR) heterodimers are the major functional forms regulating retinoid-responsive elements in adult human keratinocytes. Binding of ligands to RAR only is sufficient for RAR-RXR heterodimers to confer ligand-dependent activation of hRAR beta 2/RARE (DR5).
    Xiao JH; Durand B; Chambon P; Voorhees JJ
    J Biol Chem; 1995 Feb; 270(7):3001-11. PubMed ID: 7852380
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Retinoid x receptor agonists increase bcl2a1 expression and decrease apoptosis of naive T lymphocytes.
    Rasooly R; Schuster GU; Gregg JP; Xiao JH; Chandraratna RA; Stephensen CB
    J Immunol; 2005 Dec; 175(12):7916-29. PubMed ID: 16339527
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Suppression of human pancreatic cancer cell proliferation by AGN194204, an RXR-selective retinoid.
    Balasubramanian S; Chandraratna RA; Eckert RL
    Carcinogenesis; 2004 Aug; 25(8):1377-85. PubMed ID: 14976133
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects on gene expression in rat liver after administration of RXR agonists: UAB30, 4-methyl-UAB30, and Targretin (Bexarotene).
    Vedell PT; Lu Y; Grubbs CJ; Yin Y; Jiang H; Bland KI; Muccio DD; Cvetkovic D; You M; Lubet R
    Mol Pharmacol; 2013 Mar; 83(3):698-708. PubMed ID: 23292798
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Conformational effects on retinoid receptor selectivity. 1. Effect of 9-double bond geometry on retinoid X receptor activity.
    Jong L; Lehmann JM; Hobbs PD; Harlev E; Huffman JC; Pfahl M; Dawson MI
    J Med Chem; 1993 Sep; 36(18):2605-13. PubMed ID: 8410972
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Activation of the retinoid X receptor modulates angiotensin II-induced smooth muscle gene expression and inflammation in vascular smooth muscle cells.
    Lehman AM; Montford JR; Horita H; Ostriker AC; Weiser-Evans MC; Nemenoff RA; Furgeson SB
    Mol Pharmacol; 2014 Nov; 86(5):570-9. PubMed ID: 25169989
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Potentiation of the teratogenic effects induced by coadministration of retinoic acid or phytanic acid/phytol with synthetic retinoid receptor ligands.
    Elmazar MM; Nau H
    Arch Toxicol; 2004 Nov; 78(11):660-8. PubMed ID: 15558240
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bexarotene ligand pharmaceuticals.
    Hurst RE
    Curr Opin Investig Drugs; 2000 Dec; 1(4):514-23. PubMed ID: 11249708
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novel retinoid X receptor antagonists: specific inhibition of retinoid synergism in RXR-RAR heterodimer actions.
    Takahashi B; Ohta K; Kawachi E; Fukasawa H; Hashimoto Y; Kagechika H
    J Med Chem; 2002 Aug; 45(16):3327-30. PubMed ID: 12139443
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Retinoids increase human apo C-III expression at the transcriptional level via the retinoid X receptor. Contribution to the hypertriglyceridemic action of retinoids.
    Vu-Dac N; Gervois P; Torra IP; Fruchart JC; Kosykh V; Kooistra T; Princen HM; Dallongeville J; Staels B
    J Clin Invest; 1998 Aug; 102(3):625-32. PubMed ID: 9691099
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Retinoid X Receptor agonists as selective modulators of the immune system for the treatment of cancer.
    Leal AS; Hung PY; Chowdhury AS; Liby KT
    Pharmacol Ther; 2023 Dec; 252():108561. PubMed ID: 37952906
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modulators of the structural dynamics of the retinoid X receptor to reveal receptor function.
    Nahoum V; Pérez E; Germain P; Rodríguez-Barrios F; Manzo F; Kammerer S; Lemaire G; Hirsch O; Royer CA; Gronemeyer H; de Lera AR; Bourguet W
    Proc Natl Acad Sci U S A; 2007 Oct; 104(44):17323-8. PubMed ID: 17947383
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The MS Remyelinating Drug Bexarotene (an RXR Agonist) Promotes Induction of Human Tregs and Suppresses Th17 Differentiation
    Gaunt CM; Rainbow DB; Mackenzie RJ; Jarvis LB; Mousa HS; Cunniffe N; Georgieva Z; Brown JW; Coles AJ; Jones JL
    Front Immunol; 2021; 12():712241. PubMed ID: 34447379
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Retinoic acid isomers facilitate apolipoprotein E production and lipidation in astrocytes through the retinoid X receptor/retinoic acid receptor pathway.
    Zhao J; Fu Y; Liu CC; Shinohara M; Nielsen HM; Dong Q; Kanekiyo T; Bu G
    J Biol Chem; 2014 Apr; 289(16):11282-11292. PubMed ID: 24599963
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Activation of the orphan receptor RIP14 by retinoids.
    Zavacki AM; Lehmann JM; Seol W; Willson TM; Kliewer SA; Moore DD
    Proc Natl Acad Sci U S A; 1997 Jul; 94(15):7909-14. PubMed ID: 9223286
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Retinoid X receptor agonists modulate Foxp3⁺ regulatory T cell and Th17 cell differentiation with differential dependence on retinoic acid receptor activation.
    Takeuchi H; Yokota-Nakatsuma A; Ohoka Y; Kagechika H; Kato C; Song SY; Iwata M
    J Immunol; 2013 Oct; 191(7):3725-33. PubMed ID: 23980207
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Receptor mechanisms mediating differentiation and proliferation effects of retinoids on neuroblastoma cells.
    Hewson QC; Lova PE; Malcolm AJ; Pearson AD; Redfern CP
    Neurosci Lett; 2000 Jan; 279(2):113-6. PubMed ID: 10674634
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Novel RXR Agonist MSU-42011 Differentially Regulates Gene Expression in Mammary Tumors of MMTV-Neu Mice.
    Reich LA; Leal AS; Ellsworth E; Liby KT
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.